论文信息 - Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models - 字舞流文

Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models

A. Shaaban | J. Zuo | V. Vigneswara | K. Feldinger | Maryam Arshad | Abul Azad | Phoebe Yuen Ka Chan | S. N. M. Nafi | Eloise Laporte-Maguire | Carmela De Santo | Anthony Kong